Skip to main content

MedCloud Minute

Blog archive

ProclaimRx Launches AI-Powered Marketing Mix Modeling for Biopharma

Key Takeaways

  • ProclaimRx launches AI-powered marketing mix modeling to optimize pharmaceutical marketing budgets and campaign performance.
  • PLAiTO AI enables biopharmaceutical companies to simulate spending scenarios and accelerate marketing analytics.
  • Transparent AI recommendations connect pharmaceutical marketing decisions with underlying data, modeling assumptions, and ROI insights.

ProclaimRx, a provider of pharmacy benefit management services, has introduced an AI-powered marketing mix modeling (MMM) product designed to help commercial-stage biopharmaceutical companies analyze marketing performance and allocate budgets.

The offering uses PLAiTO, ProclaimRx's proprietary AI engine trained for pharmaceutical commercial operations, to generate models from current business data.

Marketing teams can simulate spending scenarios, identify emerging market trends and receive recommendations intended to improve return on investment.


Traditional MMM projects can require months of analysis. ProclaimRx says its platform can complete analyses that previously took weeks in hours, allowing organizations to revisit decisions as market conditions change.

The company also emphasizes model transparency. Users can trace recommendations to underlying data, analytical methods and business assumptions rather than relying on unexplained AI outputs.

For enterprise data and analytics teams, the product illustrates how industry-specific AI models are being incorporated into established business intelligence workflows.

The approach could help pharmaceutical companies connect predictive analytics with operational planning, although the reliability of recommendations depends on data quality and modeling assumptions.

ProclaimRx says the MMM product is available now.


Posted by MedCloudInsider Editors on 10/26/2026